Professor Matthew Kiernan is CEO of Neuroscience Research Australia and one of the nation's leading neurologists tackling the growing dementia crisis. Kiernan explores why dementia is now Australia's number one cause of death, the modifiable risk factors that could prevent 45% of cases, and the groundbreaking monoclonal antibody treatments now available for Alzheimer's disease. Kiernan explains how the Western Pacific region carries 60% of the world's dementia burden and why researchers are racing to develop blood biomarkers that could detect brain diseases decades before symptoms appear. We also get into:• Why dementia has overtaken heart disease as Australia's leading killer • The role of vascular health in brain function and cognitive decline • Blood biomarkers coming within five years for early detection • Monoclonal antibody treatments for Alzheimer's now available in Australia • The connection between contact sports, head injuries and neurodegeneration • How GLP-1 medications are showing promise for brain health • Sleep's critical role in clearing toxic proteins from the brain Join my exclusive Mentored+ community: https://mentored.com.au/become-a-member/ Subscribe to the Mentored newsletter here: https://mentored.com.au/newsletterSee omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related